Literature DB >> 12639945

Activin signaling through type IB activin receptor stimulates aromatase activity in the ovarian granulosa cell-like human granulosa (KGN) cells.

Chizu Mukasa1, Masatoshi Nomura, Tomoko Tanaka, Kimitaka Tanaka, Yoshihiro Nishi, Taijiro Okabe, Kiminobu Goto, Toshihiko Yanase, Hajime Nawata.   

Abstract

In addition to a stimulatory effect on FSH production by the pituitary gland, activin is thought to have a paracrine or autocrine role in follicular development in the ovary, where it is produced. Recently, we established a human ovarian granulosa tumor cell line, KGN, which possesses in vivo characteristics of granulosa cells, namely the expression of functional FSH receptors and cytochrome P-450 aromatase. Here, we have demonstrated the activin signaling pathway and its role in KGN cells. A series of transient transfection experiments revealed that activin type IB receptor (ActRIB) is an essential component of the activin signaling pathway in KGN cells. Smad2 was found to act downstream of ActRIB as an intracellular signal transmitter. Smad7, but not Smad6, was an inhibitory Smad in the pathway. Finally, we show that FSH receptor expression and cytochrome P-450 (P-450) aromatase activity was up-regulated by activin stimulation through ActRIB in KGN cells. These results show that we have clarified the signaling mechanisms and the roles of activin in the human granulosa cell line, KGN. Activin signaling mediated by ActRIB-Smad2 system in the ovary may thus be essential for the regulation of follicular differentiation.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12639945     DOI: 10.1210/en.2002-220978

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  9 in total

1.  Expression of inhibin-activin subunits, follistatin and smads in granulosa-luteal cells collected at oocyte retrieval.

Authors:  Shiuh Young Chang; Hong-Yo Kang; Kuo-Chung Lan; Chang-Yi Hseh; Fu-Jen Huang; Ko-En Huang
Journal:  J Assist Reprod Genet       Date:  2006-10-12       Impact factor: 3.412

2.  Loss of betaglycan contributes to the malignant properties of human granulosa tumor cells.

Authors:  Maree Bilandzic; Simon Chu; Paul G Farnworth; Craig Harrison; Peter Nicholls; Yao Wang; Ruth M Escalona; Peter J Fuller; Jock K Findlay; Kaye L Stenvers
Journal:  Mol Endocrinol       Date:  2009-01-22

3.  The effects of fibroblast co-culture and activin A on in vitro growth of mouse preantral follicles.

Authors:  Abbasali Karimpour Malekshah; Mahmoud Heidari; Kazem Parivar; Nasrin Sadat Azami
Journal:  Iran Biomed J       Date:  2014

4.  Invasion of ovarian cancer cells is induced byPITX2-mediated activation of TGF-β and Activin-A.

Authors:  Moitri Basu; Rahul Bhattacharya; Upasana Ray; Satinath Mukhopadhyay; Uttara Chatterjee; Sib Sankar Roy
Journal:  Mol Cancer       Date:  2015-08-23       Impact factor: 27.401

5.  Activin A Stimulates Aromatase via the ALK4-Smad Pathway in Endometriosis.

Authors:  Juan Zheng; Juan Qu; Pinhong Lu; Zhen Hou; Yugui Cui; Yundong Mao; Xiaochen Qi; Hui Ji; Jiayin Liu
Journal:  Biomed Res Int       Date:  2016-10-19       Impact factor: 3.411

6.  Effect of isopsoralen on Smad7 in osteoblastic MC3T3-E1 cells.

Authors:  Huicun Zhang; Na Ta
Journal:  Exp Ther Med       Date:  2017-06-27       Impact factor: 2.447

7.  MicroRNA-181a suppresses mouse granulosa cell proliferation by targeting activin receptor IIA.

Authors:  Qun Zhang; Haixiang Sun; Yue Jiang; Lijun Ding; Shaogen Wu; Ting Fang; Guijun Yan; Yali Hu
Journal:  PLoS One       Date:  2013-03-20       Impact factor: 3.240

8.  Loss of dmrt1 restores zebrafish female fates in the absence of cyp19a1a but not rbpms2a/b.

Authors:  Shannon Romano; Odelya H Kaufman; Florence L Marlow
Journal:  Development       Date:  2020-09-28       Impact factor: 6.862

9.  Metformin inhibits follicle-stimulating hormone (FSH) action in human granulosa cells: relevance to polycystic ovary syndrome.

Authors:  Suman Rice; Androulla Elia; Zara Jawad; Laura Pellatt; Helen D Mason
Journal:  J Clin Endocrinol Metab       Date:  2013-07-11       Impact factor: 5.958

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.